Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-170993
Filing Date
2013-04-25
Accepted
2013-04-24 18:37:04
Documents
14
Period of Report
2013-04-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d526392d6k.htm 6-K 10940
2 EX-99.1 d526392dex991.htm EX-99.1 6346
3 EX-99.2 d526392dex992.htm EX-99.2 21867
4 GRAPHIC g526392ex99_1pg1.jpg GRAPHIC 27783
5 GRAPHIC g526392ex99_2pg1.jpg GRAPHIC 102976
6 GRAPHIC g526392ex99_2pg10.jpg GRAPHIC 127483
7 GRAPHIC g526392ex99_2pg2.jpg GRAPHIC 218479
8 GRAPHIC g526392ex99_2pg3.jpg GRAPHIC 138527
9 GRAPHIC g526392ex99_2pg4.jpg GRAPHIC 165205
10 GRAPHIC g526392ex99_2pg5.jpg GRAPHIC 138323
11 GRAPHIC g526392ex99_2pg6.jpg GRAPHIC 120328
12 GRAPHIC g526392ex99_2pg7.jpg GRAPHIC 154973
13 GRAPHIC g526392ex99_2pg8.jpg GRAPHIC 164413
14 GRAPHIC g526392ex99_2pg9.jpg GRAPHIC 120623
  Complete submission text file 0001193125-13-170993.txt   2079719
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 13780450
SIC: 2834 Pharmaceutical Preparations